Phase 1 Study of ADX-626 in Healthy Participants

Clinical trial NCT07081503 · RECRUITING

Trial details

NCT number: NCT07081503
Sponsor: ADARx Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Participants

Start date: 2025-08-12
Primary completion: 2027-01-22
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.